Swing Therapeutics, founded with the mission to revolutionize chronic illness management, focuses on developing smartphone-based prescription digital treatments. Their core vision is to empower individuals with chronic conditions to thrive through innovative, evidence-based digital therapies. The company's flagship product, Stanza, is an FDA-cleared digital therapy specifically designed to alleviate symptoms of fibromyalgia, available by prescription.
Notable affiliated individuals include a team of passionate scientists, clinicians, and technologists collaborating with leading researchers. Swing Therapeutics has garnered attention for its significant achievement in obtaining FDA clearance for Stanza, marking a pivotal step in digital health solutions. The company's impact lies in offering a non-invasive, accessible treatment option that enhances the quality of life for those with chronic conditions.
